Good Science or Good Business?: An article from: The Hastings Center Report
Book Details
Author(s)David Healy
PublisherHastings Center
ISBN / ASINB0008JFT5E
ISBN-13978B0008JFT53
AvailabilityAvailable for download now
Sales Rank13,309,360
MarketplaceUnited States 🇺🇸
Description
This digital document is an article from The Hastings Center Report, published by Hastings Center on March 1, 2000. The length of the article is 2935 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
From the author: In the 1950s, estimates of the incidence of depression were fifty people per million; today the estimate is 100,000 per million. What was once defined as "anxiety" and treated with tranquilizers in the wake of the crisis of benzodiazipine dependence and the development of selective serotonin reuptake inhibitors became "depression." And as SSRIs have been shown to be effective for treating other nervous conditions, such as panic disorder, estimates of their frequency have increased markedly as well. Disease increasingly means whatever we have a reimbursable treatment for.
Citation Details
Title: Good Science or Good Business?
Author: David Healy
Publication:The Hastings Center Report (Refereed)
Date: March 1, 2000
Publisher: Hastings Center
Volume: 30 Issue: 2 Page: 19
Distributed by Thomson Gale
From the author: In the 1950s, estimates of the incidence of depression were fifty people per million; today the estimate is 100,000 per million. What was once defined as "anxiety" and treated with tranquilizers in the wake of the crisis of benzodiazipine dependence and the development of selective serotonin reuptake inhibitors became "depression." And as SSRIs have been shown to be effective for treating other nervous conditions, such as panic disorder, estimates of their frequency have increased markedly as well. Disease increasingly means whatever we have a reimbursable treatment for.
Citation Details
Title: Good Science or Good Business?
Author: David Healy
Publication:The Hastings Center Report (Refereed)
Date: March 1, 2000
Publisher: Hastings Center
Volume: 30 Issue: 2 Page: 19
Distributed by Thomson Gale










